Getaround, Inc. (GETR)
(Delayed Data from NYSE)
$0.14 USD
0.00 (0.57%)
Updated Jul 5, 2024 04:00 PM ET
After-Market: $0.14 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
F Value C Growth C Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$0.14 USD
0.00 (0.57%)
Updated Jul 5, 2024 04:00 PM ET
After-Market: $0.14 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
F Value C Growth C Momentum D VGM
Zacks News
Getaround, Inc. (GETR) Reports Q1 Loss, Lags Revenue Estimates
by Zacks Equity Research
Getaround, Inc. (GETR) delivered earnings and revenue surprises of -60% and 44.23%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Is Getaround, Inc. (GETR) Stock Outpacing Its Business Services Peers This Year?
by Zacks Equity Research
Here is how Getaround, Inc. (GETR) and Integral Ad Science (IAS) have performed compared to their sector so far this year.
Is GigaCloud Technology Inc. (GCT) Outperforming Other Business Services Stocks This Year?
by Zacks Equity Research
Here is how GigaCloud Technology Inc. (GCT) and Getaround, Inc. (GETR) have performed compared to their sector so far this year.
5 Small-Cap Stocks to Play the January Effect
by Sweta Killa
Anavex Life Sciences (AVXL), Peakstone Realty Trust (PKST), AC Immune (ACIU), Getaround (GETR) and Akoya Biosciences (AKYA) could be solid picks to play the January Effect.